Neuropace NPCE Q1 2026 Earnings EPS Beat Surprises Market Stock Gains AMWL Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Cost Controls Drive Improvement SYPR Q3 2025 Earnings Return to Profitability with EPS of 002 Passage Bio Inc PASG Q1 2026 Earnings NarrowerThanExpected Loss Fuels Share Gains BNR Q3 2022 Earnings Narrower Loss Surprises as Revenue Remains Undisclosed Local Bounti Q1 2026 Earnings EPS Beats Estimates but Stock Declines